Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I

SC Campbell, PE Clark, SS Chang, JA Karam… - The Journal of …, 2021 - auajournals.org
Purpose: This AUA Guideline focuses on evaluation/counseling/management of adult
patients with clinically-localized renal masses suspicious for cancer, including solid …

Therapeutic targeting of the hypoxic tumour microenvironment

DC Singleton, A Macann, WR Wilson - Nature reviews Clinical oncology, 2021 - nature.com
Hypoxia is prevalent in human tumours and contributes to microenvironments that shape
cancer evolution and adversely affect therapeutic outcomes. Historically, two different …

Towards a general-purpose foundation model for computational pathology

RJ Chen, T Ding, MY Lu, DFK Williamson, G Jaume… - Nature Medicine, 2024 - nature.com
Quantitative evaluation of tissue images is crucial for computational pathology (CPath) tasks,
requiring the objective characterization of histopathological entities from whole-slide images …

Management of metastatic clear cell renal cell carcinoma: ASCO guideline

WK Rathmell, RB Rumble… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide recommendations for the management of patients with metastatic
clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic …

[HTML][HTML] Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

K Bi, MX He, Z Bakouny, A Kanodia, S Napolitano… - Cancer cell, 2021 - cell.com
Immune checkpoint blockade (ICB) results in durable disease control in a subset of patients
with advanced renal cell carcinoma (RCC), but mechanisms driving resistance are poorly …

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Y Li, TSM Lih, SM Dhanasekaran, R Mannan, L Chen… - Cancer Cell, 2023 - cell.com
Clear cell renal cell carcinomas (ccRCCs) represent∼ 75% of RCC cases and account for
most RCC-associated deaths. Inter-and intratumoral heterogeneity (ITH) results in varying …

Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways

Y Zhang, F Chen, DS Chandrashekar… - Nature …, 2022 - nature.com
Mass-spectrometry-based proteomic data on human tumors—combined with corresponding
multi-omics data—present opportunities for systematic and pan-cancer proteogenomic …

Lipid metabolism in cancer: New perspectives and emerging mechanisms

LA Broadfield, AA Pane, A Talebi, JV Swinnen… - Developmental cell, 2021 - cell.com
Tumors undergo metabolic transformations to sustain uncontrolled proliferation, avoid cell
death, and seed in secondary organs. An increased focus on cancer lipid metabolism has …

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

E Jonasch, CL Walker, WK Rathmell - Nature Reviews Nephrology, 2021 - nature.com
The molecular features that define clear cell renal cell carcinoma (ccRCC) initiation and
progression are being increasingly defined. The TRACERx Renal studies and others that …

The impact of site-specific digital histology signatures on deep learning model accuracy and bias

FM Howard, J Dolezal, S Kochanny, J Schulte… - Nature …, 2021 - nature.com
Abstract The Cancer Genome Atlas (TCGA) is one of the largest biorepositories of digital
histology. Deep learning (DL) models have been trained on TCGA to predict numerous …